Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational PK/PD study of nadroparin in neonates
NL-OMON56793Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of nadroparin in Phlebothrombosis (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Primary endpoint - therapeutic nadroparin and Primary endpoint - prophylactic nadroparin. Started Apr 2025; status: recruiting.
02
Drugs
nadroparin
03
Conditions
Phlebothrombosis
Beyond the preview
Go deeper on NL-OMON56793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56793.